Literature DB >> 22789783

Comprehensive study of cationic liposomes composed of DC-Chol and cholesterol with different mole ratios for gene transfection.

Shuo-ye Yang1, Yi Zheng, Jia-yin Chen, Qiu-yang Zhang, Di Zhao, De-en Han, Xi-jing Chen.   

Abstract

The ability of cationic liposomes composed of DC-Chol and cholesterol to carry pDNA into 293 T cells was investigated. Lipoplexes formed between DC-Chol/cholesterol liposomes and pDNA (encoding green fluorescent protein, GFP) were analyzed in terms of morphology observation, turbidity determination, particle size and zeta potential measurement, differential scanning calorimetry (DSC), gel retardation assay, cytotoxicity analysis in 293 T cells and transfection efficiency. The results showed that liposome preparation at or above 66.7 mol% cholesterol in formulation exhibited a calorimetric transition caused by anhydrous cholesterol domain at about 41°C. In comparison with the control, DOPE-containing liposomes, DC-Chol/cholesterol carriers showed more stable particle size, lower turbidity, higher activity for transfecting cells in the presence of high concentration serum (50% FBS), primarily due to the neutral domain formation by increasing mole ratios of cholesterol in formulation, as well as relatively lower cytotoxicity. Based on the results, it is suggested that incorporating high contents of cholesterol might be a potentially applicable method for various kinds of cationic lipids to obtain the gene carriers with high capability for in vivo transfection.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22789783     DOI: 10.1016/j.colsurfb.2012.05.032

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  13 in total

1.  Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.

Authors:  Mingzhen Zhang; Xiaoyu Wang; Moon Kwon Han; James F Collins; Didier Merlin
Journal:  Nanomedicine (Lond)       Date:  2017-06-30       Impact factor: 5.307

Review 2.  Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.

Authors:  Anish Babu; Amanda K Templeton; Anupama Munshi; Rajagopal Ramesh
Journal:  AAPS PharmSciTech       Date:  2014-02-19       Impact factor: 3.246

3.  Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy.

Authors:  Mingzhen Zhang; Bo Xiao; Huan Wang; Moon Kwon Han; Zhan Zhang; Emilie Viennois; Changlong Xu; Didier Merlin
Journal:  Mol Ther       Date:  2016-08-05       Impact factor: 11.454

Review 4.  The Daniel K. Inouye College of Pharmacy Scripts: Targeted Nanocarrier Based Systems for the Treatment of Lung Cancer.

Authors:  Susanne R Youngren-Ortiz; Mahavir B Chougule
Journal:  Hawaii J Med Public Health       Date:  2017-11

5.  Preparation and quality evaluation of coenzyme Q10 long-circulating liposomes.

Authors:  Huibin Li; Fang Chen
Journal:  Saudi J Biol Sci       Date:  2015-11-10       Impact factor: 4.219

6.  Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system.

Authors:  Zhongyuan Wang; Yue Zhao; Yan Jiang; Wei Lv; Lin Wu; Baoyan Wang; Lingyan Lv; Qunwei Xu; Hongliang Xin
Journal:  Sci Rep       Date:  2015-07-29       Impact factor: 4.379

7.  STAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cells.

Authors:  Susanne R Youngren; Rakesh K Tekade; Brianne Gustilo; Peter R Hoffmann; Mahavir B Chougule
Journal:  Biomed Res Int       Date:  2013-09-26       Impact factor: 3.411

8.  Diacetylenic lipids in the design of stable lipopolymers able to complex and protect plasmid DNA.

Authors:  C Facundo Temprana; M Jimena Prieto; Daniela E Igartúa; A Lis Femia; M Silvia Amor; Silvia Del Valle Alonso
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

9.  Nanoliposomes for Safe and Efficient Therapeutic mRNA Delivery: A Step Toward Nanotheranostics in Inflammatory and Cardiovascular Diseases as well as Cancer.

Authors:  Meike-Kristin Abraham; Karlheinz Peter; Tatjana Michel; Hans Peter Wendel; Stefanie Krajewski; Xiaowei Wang
Journal:  Nanotheranostics       Date:  2017-04-05

10.  SATB1 siRNA-encapsulated immunoliposomes conjugated with CD44 antibodies target and eliminate gastric cancer-initiating cells.

Authors:  Feng Yang; Zhi Zheng; Luming Zheng; Jianmin Qin; Haijia Li; Xuchao Xue; Jie Gao; Guoen Fang
Journal:  Onco Targets Ther       Date:  2018-10-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.